ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Fund Overview

Fund Size

₹6,669 Cr

Expense Ratio

0.86%

ISIN

INF109KC1GH2

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

12 Jul 2018

About this fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by ICICI Prudential Mutual Fund. This fund has been in existence for 7 years, 10 months and 19 days, having been launched on 12-Jul-18.
As of 29-May-26, it has a Net Asset Value (NAV) of ₹44.93, Assets Under Management (AUM) of 6668.95 Crores, and an expense ratio of 0.86%.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given a CAGR return of 21.01% since inception.
The fund's asset allocation comprises around 96.76% in equities, 0.00% in debts, and 3.24% in cash & cash equivalents.
You can start investing in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+7.75%

+10.58% (Cat Avg.)

3 Years

+28.84%

+24.57% (Cat Avg.)

5 Years

+16.95%

+13.84% (Cat Avg.)

Since Inception

+21.01%

— (Cat Avg.)

Portfolio Summaryas of 30th April 2026

Equity	₹6,452.58 Cr	96.76%
Others	₹216.37 Cr	3.24%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹784.46 Cr	11.76%
Cipla Ltd	Equity	₹543.66 Cr	8.15%
Mankind Pharma Ltd	Equity	₹505.28 Cr	7.58%
Divi's Laboratories Ltd	Equity	₹404.47 Cr	6.06%
Dr Reddy's Laboratories Ltd	Equity	₹396.26 Cr	5.94%
Biocon Ltd	Equity	₹387.66 Cr	5.81%
Cohance Lifesciences Ltd	Equity	₹295.82 Cr	4.44%
Lupin Ltd	Equity	₹253.66 Cr	3.80%
Medplus Health Services Ltd	Equity	₹224.83 Cr	3.37%
Alkem Laboratories Ltd	Equity	₹216.17 Cr	3.24%
Syngene International Ltd	Equity	₹206.26 Cr	3.09%
Treps	Cash - Repurchase Agreement	₹146 Cr	2.19%
Akums Drugs and Pharmaceuticals Ltd	Equity	₹135.02 Cr	2.02%
Pfizer Ltd	Equity	₹130.68 Cr	1.96%
Aurobindo Pharma Ltd	Equity	₹129.01 Cr	1.93%
Abbott India Ltd	Equity	₹125.57 Cr	1.88%
Thyrocare Technologies Ltd	Equity	₹125.07 Cr	1.88%
J.B. Chemicals & Pharmaceuticals Ltd	Equity	₹118.26 Cr	1.77%
Alembic Pharmaceuticals Ltd	Equity	₹116.37 Cr	1.74%
Alivus Life Sciences Ltd	Equity	₹114.96 Cr	1.72%
Entero Healthcare Solutions Ltd	Equity	₹114.39 Cr	1.72%
Gland Pharma Ltd	Equity	₹100.65 Cr	1.51%
Blue Jet Healthcare Ltd	Equity	₹96.31 Cr	1.44%
Zydus Lifesciences Ltd	Equity	₹90.76 Cr	1.36%
Metropolis Healthcare Ltd	Equity	₹87.25 Cr	1.31%
Medi Assist Healthcare Services Ltd	Equity	₹83.08 Cr	1.25%
Fine Organic Industries Ltd Ordinary Shares	Equity	₹76.9 Cr	1.15%
Hikal Ltd	Equity	₹75.7 Cr	1.14%
Windlas Biotech Ltd	Equity	₹73.06 Cr	1.10%
Net Current Assets	Cash	₹69.97 Cr	1.05%
Aarti Drugs Ltd	Equity	₹69.05 Cr	1.04%
Sanofi Consumer Healthcare India Ltd	Equity	₹68.58 Cr	1.03%
Anthem Biosciences Ltd	Equity	₹60.04 Cr	0.90%
AstraZeneca Pharma India Ltd	Equity	₹47.87 Cr	0.72%
FDC Ltd	Equity	₹44.13 Cr	0.66%
Laxmi Dental Ltd	Equity	₹43.93 Cr	0.66%
Shilpa Medicare Ltd	Equity	₹40.45 Cr	0.61%
Nephrocare Health Services Ltd	Equity	₹27.89 Cr	0.42%
Sun Pharma Advanced Research Co Ltd	Equity	₹25.29 Cr	0.38%
Senores Pharmaceuticals Ltd	Equity	₹13.8 Cr	0.21%
Cash Margin - Derivatives	Cash - Collateral	₹0.41 Cr	0.01%

Allocation By Market Cap (Equity)

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹6,375.69 Cr	95.60%
Basic Materials	₹76.9 Cr	1.15%

Risk & Performance Ratios

Fund Managers

Dharmesh Kakkad

Since May 2020

Sharmila D’mello

Since July 2022

Additional Scheme Detailsas of 30th April 2026

ISIN

INF109KC1GH2

Expense Ratio

0.86%

Exit Load

1.00%

Fund Size

₹6,669 Cr

Age

7 years 10 months

Lumpsum Minimum

₹5,000

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Groww BSE Hospitals ETF Very High Risk	0.9%	-	₹35.39 Cr	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	0.1%	-	₹9.24 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹290.55 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	2.1%	0.0%	₹290.55 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	0.6%	1.0%	₹530.21 Cr	-
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.1%	1.0%	₹530.21 Cr	-
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.1%	1.0%	₹323.28 Cr	9.2%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.7%	1.0%	₹323.28 Cr	11.0%
PGIM India Healthcare Fund Direct Growth Very High Risk	0.8%	0.0%	₹92.44 Cr	12.7%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.5%	0.0%	₹92.44 Cr	10.8%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.6%	0.0%	₹602.93 Cr	15.2%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	0.0%	₹602.93 Cr	17.2%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹13.57 Cr	10.5%
Kotak Healthcare Fund Direct Growth Very High Risk	0.8%	0.0%	₹496.00 Cr	17.2%
Kotak Healthcare Fund Regular Growth Very High Risk	2.5%	0.0%	₹496.00 Cr	15.3%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.0%	1.0%	₹2158.58 Cr	19.1%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹2158.58 Cr	20.5%
Nippon India Pharma Fund Direct Growth Very High Risk	0.8%	1.0%	₹8365.40 Cr	6.3%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	1.6%	1.0%	₹6668.95 Cr	6.9%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	0.9%	1.0%	₹6668.95 Cr	7.7%
DSP Healthcare Fund Direct Growth Very High Risk	0.5%	0.0%	₹3142.36 Cr	9.0%
DSP Healthcare Fund Regular Growth Very High Risk	1.7%	0.0%	₹3142.36 Cr	7.5%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹84.53 Cr	10.0%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹84.53 Cr	8.6%
quant Healthcare Fund Direct Growth Very High Risk	0.8%	1.0%	₹351.89 Cr	6.8%
quant Healthcare Fund Regular Growth Very High Risk	2.5%	1.0%	₹351.89 Cr	5.1%
UTI Healthcare Fund Direct Growth Very High Risk	1.4%	1.0%	₹1143.57 Cr	11.8%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	0.9%	0.0%	₹4323.29 Cr	11.0%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	1.8%	0.0%	₹1325.19 Cr	6.5%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹1325.19 Cr	8.1%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.1%	-	₹166.87 Cr	10.6%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	1.9%	0.0%	₹4323.29 Cr	9.9%
Nippon India Pharma Fund Regular Growth Very High Risk	1.5%	1.0%	₹8365.40 Cr	5.4%
UTI Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹1143.57 Cr	10.8%
Axis NIFTY Healthcare ETF Very High Risk	0.4%	-	₹20.54 Cr	11.1%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1356.27 Cr	13.3%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.7%	1.0%	₹2939.23 Cr	13.6%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹2939.23 Cr	15.3%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	4.8%	0.0%	₹229.56 Cr	3.4%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	3.1%	0.0%	₹229.56 Cr	5.4%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹74.45 Cr	10.5%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.0%	1.0%	₹900.87 Cr	10.0%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹900.87 Cr	11.5%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.3%	-	₹41.85 Cr	9.9%

About the AMC

ICICI Prudential Mutual Fund

+91 22 26428000

https://www.icicipruamc.com/

Total AUM

₹10,78,409 Cr

Address

3rd Floor, Hallmark Business Plaza, Mumbai, 400 051

Other Funds by ICICI Prudential Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
iSIF Active Asset Allocator Long-Short Fund Direct Growth Very High Risk	-	1.0%	-	-
iSIF Equity Long-Short Fund Direct Growth Very High Risk	-	1.0%	-	-
ICICI Prudential Diversified Equity All Cap Active FOF Direct Growth Very High Risk	0.1%	1.0%	₹704.35 Cr	-
iSIF Equity Ex-Top 100 Long-Short Fund Direct Growth Very High Risk	0.6%	1.0%	₹1535.22 Cr	-
iSIF Hybrid Long-Short Fund Direct Growth Very High Risk	0.7%	1.0%	₹803.02 Cr	-
ICICI Prudential Conglomerate Fund Direct Growth Moderately High risk	1.0%	1.0%	₹824.01 Cr	-
ICICI Prudential Active Momentum Fund Direct Growth Moderate Risk	0.8%	1.0%	₹1917.99 Cr	-
ICICI Prudential Nifty Private Bank Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹24.76 Cr	-
ICICI Prudential Nifty Top 15 Equal Weight Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹25.56 Cr	-
ICICI Prudential Nifty200 Quality 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹24.90 Cr	-
ICICI Prudential Quality Fund Direct Growth Very High Risk	0.7%	1.0%	₹2169.93 Cr	1.0%
ICICI Prudential Nifty EV & New Age Automotive ETF FOF Direct Growth Very High Risk	0.7%	0.0%	₹36.86 Cr	4.5%
ICICI Prudential CRISIL-IBX Financial Services 3-6 Months Debt Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹441.14 Cr	6.6%
ICICI Prudential CRISIL-IBX AAA Bond Financial Services Index - Dec 2026 Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹8.51 Cr	-
ICICI Prudential Rural Opportunities Fund Direct Growth Moderate Risk	0.7%	1.0%	₹2104.39 Cr	-1.3%
ICICI Prudential Nifty 500 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹85.57 Cr	-0.5%
ICICI Prudential Equity Minimum Variance Fund Direct Growth Very High Risk	0.7%	1.0%	₹2984.56 Cr	0.4%
ICICI Prudential Nifty200 Value 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹230.32 Cr	21.6%
ICICI Prudential Energy Opportunities Fund Direct Growth Very High Risk	0.5%	1.0%	₹8851.29 Cr	16.7%
ICICI Prudential Fixed Maturity Plan Series 89 91 Days Plan G Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Nifty LargeMidcap 250 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹261.62 Cr	2.2%
ICICI Prudential Nifty50 Value 20 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹99.17 Cr	-5.6%
ICICI Prudential Fixed Maturity Plan Series 88 182 Days Plan J Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 125 Days Plan H Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 93 Days Plan P Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1199 Days Plan Q Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1858 Days Plan D Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1226 Days Plan F Direct Growth Low Risk	-	-	₹129.54 Cr	6.1%
ICICI Prudential Long Term Wealth Enhancement Fund Direct Growth Very High Risk	0.7%	0.0%	₹37.52 Cr	-2.0%
ICICI Prudential Fixed Maturity Plan Series 88 1828 Days Plan A Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1833 Days Plan C Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1192 Days Plan R Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 95 Days Plan B Direct Growth Moderately High risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1303 Days Plan S Direct Growth Low Risk	-	0.0%	₹62.28 Cr	5.8%
ICICI Prudential Fixed Maturity Plan Series 88 226 Days Plan E Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Thematic Advantage Fund (FOF) Direct Growth Very High Risk	1.1%	1.0%	₹8977.23 Cr	-1.0%
ICICI Prudential Floating Interest Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹7491.87 Cr	6.2%
ICICI Prudential Gilt Fund Direct Growth Low to Moderate Risk	0.5%	0.0%	₹9061.55 Cr	2.0%
ICICI Prudential All Seasons Bond Fund Direct Growth Moderately High risk	0.5%	0.0%	₹13903.19 Cr	3.8%
ICICI Prudential Long Term Bond Fund Direct Growth Moderate Risk	0.4%	0.0%	₹850.38 Cr	-1.0%
ICICI Prudential Liquid Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹54639.41 Cr	6.2%
ICICI Prudential Innovation Fund Direct Growth Very High Risk	0.6%	1.0%	₹7290.92 Cr	3.8%
ICICI Prudential Global Stable Equity Fund (FOF) Direct Growth Very High Risk	0.9%	1.0%	₹87.87 Cr	18.2%
ICICI Prudential Bond Fund Direct Growth Moderate Risk	0.5%	0.0%	₹2700.19 Cr	2.1%
ICICI Prudential Smallcap Fund Direct Growth Very High Risk	0.7%	1.0%	₹8741.30 Cr	1.5%
ICICI Prudential Midcap Fund Direct Growth Very High Risk	0.9%	1.0%	₹7556.68 Cr	18.4%
ICICI Prudential Infrastructure Fund Direct Growth Very High Risk	1.0%	1.0%	₹8311.08 Cr	4.2%
ICICI Prudential Nifty 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹16563.04 Cr	-4.3%
ICICI Prudential Regular Savings Fund Direct Growth High Risk	0.8%	1.0%	₹3288.94 Cr	4.3%
ICICI Prudential Money Market Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹32702.13 Cr	5.9%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth, as of 29-May-2026, is ₹44.93.

What are the returns of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund has generated 7.75% over the last 1 year and 28.84% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund's allocation of assets is distributed as 96.76% in equities, 0.00% in bonds, and 3.24% in cash and cash equivalents.

Who manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund managers responsible for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth are:-

Dharmesh Kakkad
Sharmila D’mello

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Fund Overview